ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Ironwood Pharmaceuticals Inc

Ironwood Pharmaceuticals Inc (IRWD)

7.88
-0.13
(-1.62%)
Closed April 14 4:00PM
8.08
0.20
(2.54%)
After Hours: 5:53PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
8.08
Bid
7.80
Ask
8.30
Volume
2,775,389
7.83 Day's Range 8.08
7.79 52 Week Range 15.70
Market Cap
Previous Close
8.01
Open
8.00
Last Trade
2
@
7.8
Last Trade Time
Financial Volume
$ 22,068,933
VWAP
7.9517
Average Volume (3m)
4,878,372
Shares Outstanding
156,528,648
Dividend Yield
-
PE Ratio
-1.23
Earnings Per Share (EPS)
-6.4
Revenue
442.74M
Net Profit
-1B

About Ironwood Pharmaceuticals Inc

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic const... Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Ironwood Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IRWD. The last closing price for Ironwood Pharmaceuticals was $8.01. Over the last year, Ironwood Pharmaceuticals shares have traded in a share price range of $ 7.79 to $ 15.70.

Ironwood Pharmaceuticals currently has 156,528,648 shares outstanding. The market capitalization of Ironwood Pharmaceuticals is $1.23 billion. Ironwood Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.23.

IRWD Latest News

Ironwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD)

– First prospective trial of a glucagon-like peptide (GLP-2) analog in SR GI aGVHD – – Results up to Day 91 show that apraglutide in SR GI aGVHD was well-tolerated with an acceptable safety...

Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

– Apraglutide met the primary endpoint of relative change from baseline in actual weekly parenteral support (PS) volume at week 24, driven by both stoma and colon-in-continuity populations – –...

Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference

– Apraglutide nutritional data from STARS Nutrition Phase 2 study in adult patients who have short bowel syndrome with intestinal failure and colon-in-continuity will be highlighted in an oral...

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance

– LINZESS® (Iinaclotide) 2023 U.S. net sales of $1.1 billion, an increase of 7% year-over-year, driven by EUTRx prescription demand growth of 10% year-over-year – – 2023 Ironwood revenue of $443...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1-1.222493887538.188.277.7921506428.0280127CS
4-0.89-9.921962095888.979.237.7939998228.62378198CS
12-4.12-33.770491803312.215.77.79487837210.7564596CS
26-1.24-13.304721039.3215.77.79351609010.68590952CS
52-2.7-25.046382189210.7815.77.79293200410.43910378CS
156-2.06-20.31558185410.1415.77.79248023011.17228519CS
260-3.82-32.100840336111.915.77.79221001810.9663406CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PXMDPaxMedica Inc
$ 0.8385
(103.59%)
114.3M
MNDRMobile health Network Solutions
$ 14.87
(45.78%)
10.66M
CNXAConnexa Sports Technologies Inc
$ 1.50
(38.89%)
16.88M
PRZOParaZero Technologies Ltd
$ 1.08
(38.46%)
12.94M
BENFBeneficient
$ 0.09542
(38.09%)
122.81M
MOTSMotus GI Holdings Inc
$ 0.2631
(-37.76%)
1.79M
CISSC3is Inc
$ 1.865
(-35.24%)
5.7M
LXEHLixiang Education Holding Company Ltd
$ 0.4325
(-33.46%)
3.12M
GVHGlobavend Holdings Ltd
$ 1.20
(-29.82%)
227.4k
SLNHSoluna Holdings Inc
$ 1.59
(-28.05%)
423.89k
SQQQProShares UltraPro Short QQQ
$ 10.89
(4.71%)
176.08M
NKLANikola Corporation
$ 0.7014
(-2.18%)
134.38M
BENFBeneficient
$ 0.09542
(38.09%)
122.81M
PXMDPaxMedica Inc
$ 0.8385
(103.59%)
114.3M
AAPLApple Inc
$ 176.55
(0.86%)
101.67M

IRWD Discussion

View Posts
Monksdream Monksdream 2 weeks ago
IRWD under $10
👍️0
philaya philaya 3 weeks ago
sold...
fast trading.
👍️0
philaya philaya 4 weeks ago
Using radar...
Got this today
👍️0
Dubster watching Dubster watching 1 month ago
B$9.01
👍️0
BabySealHugger BabySealHugger 3 years ago
Hearing rumblings of IRWD this week. Anyone else?
👍️0
whytestocks whytestocks 3 years ago
Just In: $IRWD Ironwood Pharmaceuticals Inc (IRWD) Q3 2020 Earnings Call Transcript

Image source: The Motley Fool. Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Q3 2020 Earnings Call Nov 6, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: Ironwood Pharmaceuticals Inc (IRWD) Q3 2020 Earnings Call Trans...

Find out more IRWD - Ironwood Pharmaceuticals Inc (IRWD) Q3 2020 Earnings Call Transcript
👍️0
whytestocks whytestocks 4 years ago
Just In: $IRWD Ironwood to Discontinue IW-3718 Development Program Following Results from Planned Efficacy Assessment

– Trial did not achieve statistically significant improvement in heartburn severity (primary endpoint) – – Ironwood plans to implement organizational restructuring, resulting in expected headcount reduction of approximately 100 full-time employees, or near...

In case you are interested IRWD - Ironwood to Discontinue IW-3718 Development Program Following Results from Planned Efficacy Assessment
👍️0
whytestocks whytestocks 5 years ago
News: $IRWD Ironwood and Allergan Report Positive Topline Data from Phase IIIb Trial of LINZESS® (linaclotide) in Adults with Irritable Bowel Syndrome with Constipation (IBS-C)

– Phase IIIb study met all primary and secondary endpoints with statistical significance and demonstrated that linaclotide improved the overall abdominal symptoms of bloating, pain and discomfort in adults with IBS-C – – Results further support the efficacy and s...

Got this from https://marketwirenews.com/news-releases/ironwood-and-allergan-report-positive-topline-data-from-phase-iiib-trial-of-linzess-xae-linaclotide-in-adults-with-irritable-bowel-syndrome-with-constipation-ibs-c--8377600.html
👍️0
ClayTrader ClayTrader 5 years ago
* * $IRWD Video Chart 05-17-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
stocktrademan stocktrademan 5 years ago
IRWD buy 11.365

https://www.ironwoodpharma.com/



normal chart







log chart






👍️0
chemist99 chemist99 5 years ago
epilogue

SGYP down to 3 pennies after hours today

the signs were all there, but you had to be willing to read them.

if there is a list somewhere, like, "always go on the opposite end of the trade for all recommendations from these institutions" - most of the SGYP institutional investors should definitely be on it IMHO.
👍️0
chemist99 chemist99 5 years ago
How did that work out for you;)
👍️0
chemist99 chemist99 6 years ago
knew all too well what was going on behind the Synergy scenes;

http://www.nj.com/business/index.ssf/2012/08/bristol-myers_drug_flop_erases.html


if you make a multinational company lose a couple billion $ in short order & leave them stuck with trial deaths, AND expect anyone in the pharmaceutical industry ever to trust you again, you need to have your head examined imo. he's probably looking under his car every morning...

there's a really nice package deal available for you though from the experienced crew, if you're still game for it:

Synergy, $6 in January, now on sale at $1.90, Trovagene, went public at $24, now marked down to 51 cents for quick clearance, and ContraVir, $5 as recently as 2015, but now available for just 49 cents! Yes, you get all three of these made-to-be-sold companies for just $2.90! And, if you act now, we'll throw in 10 shares of Callisto Pharmaceuticals, a company which sank beneath the waves with Cap'n Gary at the helm!

👍️0
chemist99 chemist99 6 years ago
Enjoy the front row seat to the final act of the drama, sure was expensive enough...
👍️0
chemist99 chemist99 6 years ago
Q.e.d.
👍️0
Inoviorulez Inoviorulez 7 years ago
https://seekingalpha.com/article/4089539-ironwood-will-press-good-fight-gerd
👍️0
chemist99 chemist99 7 years ago
:(
👍️0
chemist99 chemist99 7 years ago
:)
👍️0
chemist99 chemist99 8 years ago
Brilliant !
👍️0
brownsfan407 brownsfan407 8 years ago
I did 10,000 shares on that one, didn't get in at the low, but out close to the top. Flipped it into sgyp in the low 3's
👍️0
chemist99 chemist99 8 years ago
thanks for bringing it to my attention! that was nice, ~7.30s to $10.24 in less than a month, 30+% !
Hope you didn't miss it :) ?
👍️0
brownsfan407 brownsfan407 8 years ago
you were right, we saw 7's this week. 52 week low
👍️0
chemist99 chemist99 9 years ago
SGYP short volume 25 million plus now...looks like the hedgefunds are in the business to lose money then ?
👍️0
brownsfan407 brownsfan407 9 years ago
under 10 coming your way soon. the trend is your friend
👍️0
brownsfan407 brownsfan407 9 years ago
IRWD, 10.71 new 52 week low fact, not rant
8.00 in September lows
👍️0
chemist99 chemist99 9 years ago
no pain data, skewed side effect profile = no partner IMO.

no partner = slim chance, if any, of competing in the marketplace for a primary care drug with an army of people promoting the first-to-market competitor, IMO.

simple as that.

rant all you want. doesn't change the fact that Phase III CIC data are out - and still no buyout & no partnership despite the "hey we're for sale" press article LOL.

that, and the low (~30%) institutional ownership of SGYP compared with IRWD (~100%), combined with the ~22 mill. short volume for SGYP speak volumes...



👍️0
brownsfan407 brownsfan407 9 years ago
IRWD pennies of 51 week low, while market booms. Stock price heading in the same direction as the diarrhea it causes. despite misinformation by IRWD propagandist.. BTW, I bought a boatload of warrants at .36, now 4.00. I can be very patient for the next explosion. 2 phase 3 results and an NDA by year end
👍️0
brownsfan407 brownsfan407 9 years ago
from an IRWD board? nice, just a little biased. Don't try to be naïve, you have no idea what is going on behind the scenes. and like I said you have lots of holders, but yahoo stats says 3 percent own over 5 percent, and that 3 percent includes insider holdings. Everyone owns a little. Cerrone TOOK 1/2 year with inhibitex, to get top buck, we have only been a month here. 4 catalysts by year end. we are up 165 percent, you? your short at 4 dollars is a FAILED trade
👍️0
chemist99 chemist99 9 years ago
sooner or later the Wall Street hysteria, fanned by a couple of hyperbolic analyst op ed pieces, will be over; - the music will stop, people will wake up & valuations will adjust to reality. they always do.

I quote a comment of someone from "the trenches" posted on the IRWD CP board, who puts it in quite simple (& blunt) terms:

anonymous, Jul 22, 2015 at 9:37 AM
(quote) ...." Less diarrhea, yes but with that is less efficacy. You can't treat cic with no diarrhea and have the same efficacy. So you think you can hire a third of the reps ? So roughly 1 rep per state to grow the constipation market of 50 million? This is a primary care drug linzess has over 3000 people promoting it. When it is all said and done 80 percent of volume will come from pcp. You need a partner and despite your so called stellar efficacy and no side effects no one is stepping up. No pain data and skewed side effect data equals no partner. We developed plecanatide and linaclotide and kept linzess. I'm gonna go with the MIT scientists who discovered GCC on this one..."

http://www.cafepharma.com/boards/threads/we-should-buy-synergy.583049/

👍️0
brownsfan407 brownsfan407 9 years ago
I don't know the answer, but do you think they are happy with the price DEpreciation, under 11, it has been YEARS since it has been that low
👍️0
chemist99 chemist99 9 years ago
IRWD:
% of Shares Held by Institutional & Mutual Fund Owners: 110%
% of Float Held by Institutional & Mutual Fund Owners: 112%
Number of Institutions Holding Shares: 163

SGYP:
% of Shares Held by Institutional & Mutual Fund Owners: 29%
% of Float Held by Institutional & Mutual Fund Owners: 32%
Number of Institutions Holding Shares: 90

source: Yahoo finance 07/22/15
👍️0
brownsfan407 brownsfan407 9 years ago
% of Shares Held by All Insider and 5% Owners: 2 percent. surprisingly low. lots with their toes in the water, but no ringing endorsements
👍️0
brownsfan407 brownsfan407 9 years ago
I can explain the price drop in facts, but I can't help you to understand it
👍️0
brownsfan407 brownsfan407 9 years ago
Chemist, you the only one here? Looks like it
👍️0
brownsfan407 brownsfan407 9 years ago
but our price is going up, I am sorry, which way is this price going? It is not going to be long before our price eclipses yours
👍️0
chemist99 chemist99 9 years ago
Sgyp new short volume ~ 22 mill; - go figure ??
👍️0
brownsfan407 brownsfan407 9 years ago
chemist, short up to 17 mill, too bad you can't use your moniker to reformulate this drug into something better, but then again, what chemistry do you need to use a virus?
👍️0
brownsfan407 brownsfan407 9 years ago
hot 6 page found in nature thing working for you? I am having trouble with my pixels, did wedbush lower the target to 11? that's lower than the current price
👍️0
brownsfan407 brownsfan407 9 years ago
6/15 was days before the phase 3 results. I bet some more shorted the 9 down to 8 to cover the earlier bad trade. We hire 2 more big guns today, and the pump articles and increasing price targets are like ants around a popsicle on a picnic, they are everywhere. Synergy will do ma secondary at 13, pay back the loan, and actually lower their share count, and knock off the interest
👍️0
chemist99 chemist99 9 years ago
yes, IRWD short interest up to ~16 million shares, but SGYP up even more to about ~21.5 million shares per 06/15 :
http://www.nasdaq.com/symbol/sgyp/short-interest

the hedge funds must be in the business to lose money, I guess...
👍️0
brownsfan407 brownsfan407 9 years ago
Chemist, Last SI up 2 million, are there folks betting on this going down. are you hedged? Sgyp set to double
👍️0
brownsfan407 brownsfan407 9 years ago
How about your long position here? 1/3 the diarrhea rate for plecanatide, and filing NDA in November. Has to severely stunt the growth here. What is the adage, the market is forward looking? However, maybe you can clarify. The guy who took IRWD through the NDA process, does he still work for you?
👍️0
brownsfan407 brownsfan407 9 years ago
In a few months the ticker symbol for Synergy may not exist, in a perfect world
👍️0
chemist99 chemist99 9 years ago
No short no loss. Let's compare notes again in a few months. Enjoy it while it lasts??
👍️0
brownsfan407 brownsfan407 9 years ago
what did you lose on the short? 6 bucks per share? and now, your long shares here are severely compromised. I would have some compassion for you if it were not for your past smugness and haughtiness
👍️0
brownsfan407 brownsfan407 9 years ago
Game, set, match, plecanatide is clearly better. Cannot dispute the numbers, as the 600 rode the 89 percent gain
👍️0
chemist99 chemist99 9 years ago
oh well, it served it's purpose, I suppose :)
👍️0
brownsfan407 brownsfan407 9 years ago
check out lpcn, oral trt, NDA BY Q3, pre-term birth PILL too. Low float monster
👍️0
chemist99 chemist99 9 years ago
lol.

a little knowledge can be a dangerous thing.
👍️0
brownsfan407 brownsfan407 9 years ago
Oh, btw, I owe you all the mortgage payments I was anble to make cus of you and your bosses. You guys drove the price down on SGYP I was able to sell at 4.50 the shares you bought down to the mid 2's. I also flipped some warrants from .60 t0 1.20 for a nifty double. Could NOT have donneit with out you.
👍️0

Your Recent History

Delayed Upgrade Clock